Exemestane and Finasteride Interaction
Exemestane and Finasteride have a potentially harmful interaction with 75% confidence. Both Exemestane and Finasteride carry hepatotoxic risk. Combining hepatotoxic compounds significantly increases liver damage potential. If unavoidable, include liver support (TUDCA/NAC) and monitor ALT/AST frequently. These compounds primarily affect different organ systems.
Compound Profiles
Exemestane
Steroidal Aromatase Inhibitor | Irreversible Estrogen Control
Exemestane functions as a mechanism-based (suicide) inhibitor of aromatase (cytochrome P450 19A1). Due to its steroidal structure, exemestane is recognized by aromatase as a substrate analogue and enters the enzyme's active site.
View full profileFinasteride
5-Alpha Reductase Inhibitor | DHT Blocker for Hair Loss & BPH
Finasteride competitively and selectively inhibits the Type II isoform of the enzyme 5-alpha reductase, which is predominantly found in hair follicles, the prostate, and the liver. This enzyme converts testosterone into dihydrotestosterone (DHT).
View full profileCombined Organ Load
Shared Safety Flags
Frequently Asked Questions
Can I take Exemestane with Finasteride?
Combining Exemestane with Finasteride is not recommended. Both Exemestane and Finasteride carry hepatotoxic risk. Combining hepatotoxic compounds significantly increases liver damage potential. If unavoidable, include liver support (TUDCA/NAC) and monitor ALT/AST frequently.
Is Exemestane and Finasteride safe together?
This combination carries significant risk. Both Exemestane and Finasteride carry hepatotoxic risk. Combining hepatotoxic compounds significantly increases liver damage potential. If unavoidable, include liver support (TUDCA/NAC) and monitor ALT/AST frequently. Consult a healthcare professional before combining.
What are the interactions between Exemestane and Finasteride?
Both Exemestane and Finasteride carry hepatotoxic risk. Combining hepatotoxic compounds significantly increases liver damage potential. If unavoidable, include liver support (TUDCA/NAC) and monitor ALT/AST frequently. This assessment has 75% confidence and is inferred from pharmacological mechanism analysis.
How should I time Exemestane and Finasteride?
Exemestane has a half-life of ~24 hours and Finasteride has a half-life of 6-8 hours (DHT suppression persists ~24 hours). No specific timing requirements identified for this combination, but separating administration can help monitor individual effects.
This interaction analysis is compiled from research literature and pharmacological mechanism data. This assessment is inferred from known mechanisms and may not reflect all real-world outcomes. Always consult a healthcare professional before combining compounds.